Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
  1. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,484 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 13,096 shares (to pay taxes)
  3. 4 Grant or award Interim CFO acquired 60,859 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 60,859 shares (grant or award)
  5. 4 Grant or award Chief Legal Officer and GC acquired 60,859 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 320,312 shares (grant or award)
  7. 4 Open-market buy Director bought 12,500 shares at $1.60 ($20,000)
  8. 4 Open-market sale 10% owner sold 250,000 shares at $1.74 ($435,000)
  9. 4 Open-market sale 10% owner sold 250,000 shares at $1.84 ($460,000)
  10. 4 Open-market sale 10% owner sold 338,897 shares at $2.23 ($755,740)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Interim CFO gave up 700 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Commercial Officer gave up 5,151 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Scientific Officer gave up 3,083 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 3,551 shares (to pay taxes)

Page 9 of 17 · 330 filings